FEATURE The smart money seems to be calling a bottom for the healthcare sector. That could mean it’s time for investors to start taking another look at the industry’s more beleaguered stocks. Since the ...
In the closing of the recent trading day, Pfizer (PFE) stood at $29.18, denoting a -0.07% change from the preceding trading day.
Bourla and Shantanu Narayen, Pfizer's lead independent director and Adobe Systems CEO, will hold talks with Starboard chief executive Jeff Smith and Patrick Sullivan, who runs its healthcare investments, the report said. Reuters reported on Sunday, citing sources, that Starboard Value had taken a stake of about $1 billion in Pfizer and wanted the drugmaker to make changes to turn its performance around.